Algert Global LLC Care Dx, Inc. Transaction History
Algert Global LLC
- $4.04 Billion
- Q1 2025
A detailed history of Algert Global LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Algert Global LLC holds 21,390 shares of CDNA stock, worth $407,051. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,390
Previous 36,040
40.65%
Holding current value
$407,051
Previous $772,000
50.78%
% of portfolio
0.01%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding CDNA
# of Institutions
230Shares Held
56.9MCall Options Held
51.2KPut Options Held
46K-
Black Rock Inc. New York, NY5.29MShares$101 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$92 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.67MShares$50.8 Million0.01% of portfolio
-
State Street Corp Boston, MA2.48MShares$47.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.35MShares$44.7 Million0.45% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.02B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...